Medtronic is celebrating the success of its PulseSelect pulsed field ablation product by highlighting its impact on heart patients around the world. 

While Stephen Matthews sits in jail for allegedly raping women he met online, lawmakers are saying his case is evidence that dating apps need to be better regulated.

Heart teams have several options when patients present with stable chest pain and require further testing. According to a brand new analysis of nearly 800 patients, CCTA may be the best place to start. 

New research out of Texas could go a long way toward improving care for patients with acute decompensated heart failure.

According to the FDA, using these devices without following manufacturer recommendations could lead to “serious injuries or death." 

The newly approved device is much smaller than previous offerings, helping operators capture 3D images during structural heart evaluations. 

The FDA’s final decision was based largely on positive results from the ADVENT clinical trial, which compared treatment with the Farapulse PFA System to the current standard of care.

Annual SAVR volumes in the United States decreased by a whopping 44.5% from 2012 to 2022. However, heart teams across the country seem to agree that surgery is a safer, more effective treatment option than TAVR when patients present with bicuspid aortic valves. 

Jeremy Slivnick, MD, spoke with Cardiovascular Business about AI's potential to transform how cardiac amyloidosis is diagnosed and treated. 

Injuries to the esophagus remain a common complication associated with radiofrequency ablation procedures. New research suggests a device developed by S4 Medical could significantly reduce the risk of such injuries.